SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valerio Zerbi, Diane Jansen, Pieter J. Dederen, Andor Veltien, Bob Hamans, Yang Liu, Arend Heerschap, Amanda J. Kiliaan, Microvascular cerebral blood volume changes in aging APPswe/PS1dE9 AD mouse model: a voxel-wise approach, Brain Structure and Function, 2012,

    CrossRef

  2. 2
    Pedro M. Pimentel-Coelho, Serge Rivest, The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease, European Journal of Neuroscience, 2012, 35, 12
  3. 3
    Jerzy Leszek, Marta Sochocka, Kazimierz Gąsiorowski, Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease, Journal of the Neurological Sciences, 2012, 323, 1-2, 25

    CrossRef

  4. 4
    J. Dumont, D. Meroufel, C. Bauters, F. Hansmannel, F. Bensemain, D. Cottel, M. Hamon, J.-C. Lambert, P. Ducimetiere, P. Amouyel, M. Zureik, T. Brousseau, Association of Ornithine Transcarbamylase Gene Polymorphisms With Hypertension and Coronary Artery Vasomotion, American Journal of Hypertension, 2009, 22, 9, 993

    CrossRef

  5. 5
    Carlijn R. Hooijmans, Amanda J. Kiliaan, Fatty acids, lipid metabolism and Alzheimer pathology, European Journal of Pharmacology, 2008, 585, 1, 176

    CrossRef

  6. 6
    L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, C. Iadecola, Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein, Proceedings of the National Academy of Sciences, 2008, 105, 4, 1347

    CrossRef

  7. You have open access to this content7
    Patrick C. Reid, Yasuomi Urano, Tatsuhiko Kodama, Takao Hamakubo, Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins, Journal of Cellular and Molecular Medicine, 2007, 11, 3
  8. 8
    Erik Scherder, Laura Eggermont, Joseph Sergeant, Froukje Boersma, Physical Activity and Cognition in Alzheimer's Disease: Relationship to Vascular Risk Factors, Executive Functions and Gait, Reviews in the Neurosciences, 2007, 18, 2

    CrossRef

  9. 9
    L. H. Kuller, Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2006, 61, 12, 1314

    CrossRef

  10. 10
    S.L. Cole, R. Vassar, Isoprenoids and Alzheimer's disease: A complex relationship, Neurobiology of Disease, 2006, 22, 2, 209

    CrossRef

  11. 11
    Y. Fujiwara, P. H. M. Chaves, R. Takahashi, H. Amano, H. Yoshida, S. Kumagai, K. Fujita, D. G. Wang, S. Shinkai, Arterial Pulse Wave Velocity as a Marker of Poor Cognitive Function in an Elderly Community-Dwelling Population, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2005, 60, 5, 607

    CrossRef

  12. 12
    Laura Fratiglioni, Stephanie Paillard-Borg, Bengt Winblad, An active and socially integrated lifestyle in late life might protect against dementia, The Lancet Neurology, 2004, 3, 6, 343

    CrossRef

  13. 13
    Walter Kalback, Chera Esh, Eduardo M. Castaño, Afroza Rahman, Tyler Kokjohn, Dean C. Luehrs, Lucia Sue, Raquel Cisneros, Francoise Gerber, Claudia Richardson, Bernd Bohrmann, Douglas G. Walker, Thomas G. Beach, Alex E. Roher, Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease, Neurological Research, 2004, 26, 5, 525

    CrossRef

  14. 14
    James A.R. Nicoll, Masahito Yamada, Janusz Frackowiak, Bozena Mazur-Kolecka, Roy O. Weller, Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease, Neurobiology of Aging, 2004, 25, 5, 589

    CrossRef

  15. 15
    Joann T. Tschanz, John C. S. Breitner, Alzheimer's Disease: Risk Factors and Preventive Strategies,